Suven Life Sciences completes enrollment in global Phase 3 masupirdine study
Suven Life Sciences Ltd has completed patient enrollment in its global Phase 3 masupirdine study.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Suven Life Sciences Ltd has completed patient enrollment in its global Phase 3 masupirdine study.